JUN and cancer: Our pan-cancer analysis revealed that elements from a primate-specific ERV named long terminal repeat 10 (LTR10) show enhancer activity in many epithelial tumors, and this activity is regulated by signaling pathways involving mitogen-activated protein kinase (MAPK) and activator protein 1 (AP1).